Brief: S.Korea's Hugel Says Receives Approval To Sell Botulax In Taiwan
Dec 4 (Reuters) - Hugel Inc 145020.KQ :
* SAYS RECEIVES APPROVAL TO SELL BOTULAX IN TAIWAN
Source text for Eikon: https://bit.ly/2zPD5Ar
Further company coverage: 145020.KQ
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))
Recent news on Hugel
See all newsBrief: Hugel To Cancel 54 Billion Won Worth Of Own Shares
Brief: Hugel Q3 Operating Profit 18 Billion Won, Down 62% From Year Earlier
Brief: Hugel Reports Q2 2026 Net Sales Up 25.1% TO KRW 137.90 Billion
Brief: Hugel Q4 Operating Profit 58.6 Billion Won, Up 26% From Year Earlier
Brief: Hugel Q3 Operating Profit 47.4 Billion Won, Down 11% From Year Earlier